DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lipsky AH, Farooqui MZ, Tian X. et al.
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica 2015;
100 (12) 1571-1578
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.